MELAX EXECUTIVE TEAM

Innovative, Collaborative, Professional. Explore for advance clinical data analysis.

MELAX EXECUTIVE TEAM

Image

Hua Xu

CEO

Dr. Xu is the Founder and CEO of Melax Technologies Inc. After finishing his PhD from Columbia University, he has worked as a professor of biomedical informatics at Vanderbilt University and The University of Texas Health Science Center at Houston (UTHealth), focusing on the research area of biomedical NLP. In the past decade, he has worked on a broad range of challenging NLP topics and clinical NLP methods and systems developed in his lab have been highly recognized. He served as the Chair of AMIA (American Medical Informatics Association) NLP Working Group in 2013-14. Currently he leads the NLP Working Group at the OHDSI (Observational Healthcare Data Science and Informatics) consortium.

Image

Frank Manion

VP for Innovation

Dr. Manion is the VP for Innovation, who has held positions in high level clinical and bioinformatics executive support roles at two major NCI-designated NCI comprehensive cancer centers. He directed research computing and bioinformatics support for the Fox Chase Cancer Center, and biomedical informatics support at the Rogel Cancer Center at the University of Michigan for 9 years. He participated in two major NIH-funded human genome centers. At the University of Michigan, he helped develop major initiatives around scientific data representation standards and information systems interoperability architecture for the Medical School.

Image

Jingqi Wang

NLP Architect

Jingqi Wang serves as an NLP Architect at Melax Technologies Inc, leading the NLP development team. He has ten years of working experience as a software developer before he joined Melax. In the past years, he primarily worked on the development and improvement of clinical Natural Language Processing (NLP) algorithms and applications. He has contributed to multiple top-ranked systems in biomedical NLP competitions.

Image

Richard Wagner

Sales Account Manager

Richard has been a top performing healthcare software sales and management professional with over 25 years’ experience with measurable results. He is experienced in creating market presence and building relationships with both large, billion dollar companies and small start-up companies.

Image

Yaoyun Zhang

Director of NLP Technology

Yaoyun Zhang serves as the Director of NLP Technology in Melax. Before joining Melax, she was an Assistant Professor in The University of Texas Health Science Center at Houston. Her primary research interests include natural language processing (NLP), text mining and machine learning. In the past eight years, she has contributed to multiple top ranked systems in biomedical NLP competitions. Her research also contributed to Pharmacovigilance and genetic information extraction from clinical trials. Furthermore, Yaoyun’s research interest focuses on transfer learning and unsupervised learning methodologies to alleviate the heavy load of manual corpus curation in the biomedical domain. 

Image

Hao Ding

Operational Manager
A biophysicist by training, Hao was fascinated by natural language processing, machine learning, and the impact of new technology that will bring to the healthcare industry. Since joining Melax Technologies in 2018, Hao has been passionate about expanding business development and revenue generation, managing company daily operation, and ultimately contributing to the improvement of the healthcare system. When not working hard in front of his computer, Hao enjoys spending time with his family and sweating in the gym.
© 2020 Melax. All Rights Reserved.